Approval · Notice of Compliance 30046 · 2023
FLUCONAZOLE: Notice of Compliance 30046
Issued February 2, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30046
- Date
- February 2, 2023
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- DIFLUCAN (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUCONAZOLE | 02534886 | Marketed |
| FLUCONAZOLE | 02534894 | Marketed |
Medicinal ingredients
- FLUCONAZOLE 50 MG per TAB
- FLUCONAZOLE 100 MG per TAB